Clinical-Use-Associated Decrease in Susceptibility of Vancomycin-Resistant <i>Enterococcus faecium</i> to Linezolid: a Comparison with Quinupristin-Dalfopristin

Issam Raad(Missouri Department of Agriculture), Louis B. Rice(Brown University), Gassan Chaiban(The University of Texas MD Anderson Cancer Center), Tanya Dvorak(The University of Texas MD Anderson Cancer Center), Hend Hanna(The University of Texas MD Anderson Cancer Center), Rebecca Arbuckle(The University of Texas MD Anderson Cancer Center), Ray Hachem(The University of Texas MD Anderson Cancer Center)
Antimicrobial Agents and Chemotherapy
August 24, 2004
Cited by 54


Related Papers